Ming-Hui Chen Selected Research

Post-Exercise Hypotension

1/2019	FURIN variant associations with postexercise hypotension are intensity and race dependent.
11/2017	Deep-targeted sequencing of endothelial nitric oxide synthase gene exons uncovers exercise intensity and ethnicity-dependent associations with post-exercise hypotension.
10/2016	Deep-targeted exon sequencing reveals renal polymorphisms associate with postexercise hypotension among African Americans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Hui Chen Research Topics

Disease

131	Prostatic Neoplasms (Prostate Cancer) 10/2022 - 05/2002
42	Neoplasms (Cancer) 03/2022 - 07/2002
12	Adenocarcinoma 01/2022 - 05/2007
9	Myocardial Infarction 01/2016 - 06/2007
9	Carcinoma (Carcinomatosis) 01/2011 - 07/2002
6	Cardiovascular Diseases (Cardiovascular Disease) 10/2018 - 05/2010
6	Heart Failure 01/2016 - 08/2009
5	Hepatocellular Carcinoma (Hepatoma) 01/2011 - 07/2007
5	Neoplasm Metastasis (Metastasis) 02/2010 - 05/2005
4	Breast Neoplasms (Breast Cancer) 01/2020 - 10/2006
3	Post-Exercise Hypotension 01/2019 - 10/2016
3	Glioma (Gliomas) 01/2018 - 10/2015
3	Obesity 01/2017 - 01/2014
3	Diabetes Mellitus 01/2016 - 08/2010
3	Coronary Artery Disease (Coronary Atherosclerosis) 09/2015 - 08/2009
3	Hemorrhage 12/2014 - 09/2003
3	Margins of Excision 11/2010 - 09/2002
2	Melanoma (Melanoma, Malignant) 12/2020 - 11/2012
2	Chronic Disease (Chronic Diseases) 01/2020 - 10/2018
2	Hypertension (High Blood Pressure) 01/2019 - 02/2012
2	7 Hereditary Prostate Cancer 01/2016 - 01/2016
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2014 - 01/2014
2	Type 2 Diabetes Mellitus (MODY) 04/2014 - 06/2012
2	Bone Diseases (Bone Disease) 11/2004 - 09/2003
1	Ovarian Neoplasms (Ovarian Cancer) 03/2022
1	Rare Diseases (Rare Disease) 01/2022
1	Pain (Aches) 11/2021
1	Back Pain (Backache) 05/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2020
1	Retinoblastoma (Glioblastoma, Retinal) 01/2020
1	Pediatric Obesity 11/2019
1	Hypercholesterolemia 01/2019
1	Atherosclerosis 01/2019
1	Coronary Disease (Coronary Heart Disease) 01/2019
1	Malaria 11/2018
1	Prehypertension 01/2017

Drug/Important Bio-Agent (IBA)

64	Prostate-Specific Antigen (Semenogelase)IBA 01/2021 - 05/2002
60	AndrogensIBA 01/2022 - 07/2002
8	Biomarkers (Surrogate Marker)IBA 02/2021 - 09/2003
7	Hormones (Hormone)IBA 01/2014 - 05/2005
6	Testosterone (Sustanon)FDA Link 01/2021 - 10/2007
5	Gonadotropin-Releasing Hormone (GnRH)FDA Link 07/2012 - 06/2008
4	Pharmaceutical PreparationsIBA 01/2022 - 09/2011
4	EnzymesIBA 12/2020 - 06/2006
4	AntioxidantsIBA 10/2018 - 01/2015
3	Androgen Antagonists (Antiandrogens)IBA 07/2012 - 06/2008
3	acarboxyprothrombin (PIVKA)IBA 01/2009 - 12/2008
3	Matrix Metalloproteinases (MMPs)IBA 11/2008 - 06/2006
2	Vitamin E FDA LinkGeneric 03/2022 - 02/2021
2	SeleniumIBA 03/2022 - 02/2021
2	16S Ribosomal RNAIBA 03/2022 - 10/2012
2	LipidsIBA 03/2022 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2022 - 11/2021
2	Vancomycin FDA LinkGeneric 03/2022 - 10/2004
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2015
2	Hypoglycemic Agents (Hypoglycemics)IBA 04/2014 - 06/2012
2	Prothrombin (Factor II)IBA 01/2009 - 12/2008
2	Blood Proteins (Serum Proteins)IBA 01/2009 - 12/2008
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 10/2006 - 06/2006
1	Arginine (L-Arginine)FDA Link 03/2022
1	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 03/2022
1	Amino Acids FDA Link 03/2022
1	Bile Acids and Salts (Bile Acids)IBA 03/2022
1	Neomycin FDA LinkGeneric 03/2022
1	Proline (L-Proline)FDA Link 03/2022
1	SphingolipidsIBA 03/2022
1	Glycerophospholipids (Phosphoglycerides)IBA 03/2022
1	AntigensIBA 02/2021
1	neferineIBA 12/2020
1	p38 Mitogen-Activated Protein KinasesIBA 12/2020
1	IodidesIBA 12/2020
1	ImmunosorbentsIBA 12/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	RNA Splicing FactorsIBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	SugarsIBA 11/2019
1	LDL CholesterolIBA 01/2019
1	CholesterolIBA 01/2019
1	FurinIBA 01/2019
1	Ezetimibe (Zetia)FDA Link 01/2019
1	oxidized low density lipoproteinIBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	artemisinin (artemisinine)IBA 11/2018
1	LactonesIBA 11/2018
1	SesquiterpenesIBA 11/2018
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2017
1	Oxygen (Dioxygen)IBA 01/2017
1	adducinIBA 10/2016
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 10/2016

Therapy/Procedure

89	Therapeutics 01/2022 - 07/2002
71	Radiotherapy 10/2022 - 07/2002
41	Prostatectomy (Retropubic Prostatectomy) 10/2022 - 05/2002
33	Brachytherapy 01/2022 - 09/2003
3	Aftercare (After-Treatment) 01/2021 - 06/2003
2	Drug Therapy (Chemotherapy) 11/2013 - 05/2005
2	Combined Modality Therapy 10/2012 - 09/2003
2	Stents 11/2011 - 06/2010
1	Feeding Methods 11/2021
1	Pain Management 05/2021
1	Lymph Node Excision (Lymph Node Dissection) 01/2019